Age-related markers and predictors of diabetic kidney disease progression in type 2 diabetes patients: a retrospective cohort study

被引:6
作者
Fabre, Larissa [1 ,2 ]
Rangel, Erika Bevilaqua [3 ,4 ]
机构
[1] Univ Fed Sao Paulo, Dept Med, Nephrol Div, Sao Paulo, SP, Brazil
[2] Hosp Reg Hans Dieter Schmidt, Joinville, SC, Brazil
[3] Univ Fed Sao Paulo, Dept Med, Nephrol Div, Borges Lagoa St,591,6th floor,Vila Clementino, BR-04038031 Sao Paulo, SP, Brazil
[4] Hosp Israelita Albert Einstein, Albert Einstein Res & Educ Inst, Sao Paulo, SP, Brazil
关键词
aging; albuminuria; diabetes; glomerular filtration rate; kidney disease; PREVALENCE; NEPHROPATHY; METAANALYSIS; POPULATION; GUIDELINES; DIALYSIS; MELLITUS; FRAILTY; RISK;
D O I
10.1177/20420188241242947
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Diabetic kidney disease (DKD) is characterized by reduced estimated glomerular filtration rate (eGFR) and albuminuria, which play a pivotal role in both diagnosing and determining the disease's progression. This study aimed to assess the trajectory of these markers concerning age in individuals with DKD and identify predictive factors for the decline in eGFR decline, variation in albuminuria, mortality, and progression to renal replacement therapy (RRT). Design: This retrospective cohort encompassed patients with type 2 diabetes (T2D), divided into two age categories: <75 and >75 years old. Methods: Over a 3-year span, the study evaluated eGFR (CKD-EPI) and 24-h albuminuria. Univariate and multivariate analyses were employed to pinpoint factors associated with deteriorating renal function and mortality. Significance was set at p < 0.05, and Kaplan-Meier survival curves were constructed to illustrate renal and overall survival. Results: The analysis comprised 304 patients. Comparable eGFR declines were evident in both age groups during the transition from the first to the second year and from the second to the third year. Nonetheless, a more pronounced rise in albuminuria was evident in the >75 years group during the first to the second year. Multivariate analysis unveiled that systolic blood pressure (SBP) measurements in the first year positively forecasted eGFR decline. Age was associated with heightened albuminuria and mortality, while hospitalizations linked to cardiovascular causes robustly predicted mortality. Hospitalizations due to sepsis and cardiovascular reasons, coupled with first-year SBP measurements, served as predictive indicators for progression to RRT. Conclusion: Both age groups experienced similar declines in eGFR, though the >75 years group displayed a more significant increase in albuminuria during the first to the second year. Age, hospitalizations, and higher blood pressure levels were correlated with exacerbated renal function deterioration and/or elevated mortality in DKD. Timely intervention and tailored management strategies stand as critical components for enhancing outcomes among DKD patients.
引用
收藏
页数:20
相关论文
共 51 条
  • [1] Abbafati C, 2020, LANCET, V396, P1204
  • [2] Aitken Grant R, 2014, BMJ Open, V4, pe005480, DOI 10.1136/bmjopen-2014-005480
  • [4] [Anonymous], 2002, DEF OLD ELD PERS
  • [5] Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy
    Bakris, GL
    Copley, JB
    Vicknair, N
    Sadler, R
    Leurgans, S
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (05) : 1641 - 1650
  • [6] Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
    Bikbov, Boris
    Purcell, Carrie
    Levey, Andrew S.
    Smith, Mari
    Abdoli, Amir
    Abebe, Molla
    Adebayo, Oladimeji M.
    Afarideh, Mohsen
    Agarwal, Sanjay Kumar
    Agudelo-Botero, Marcela
    Ahmadian, Elham
    Al-Aly, Ziyad
    Alipour, Vahid
    Almasi-Hashiani, Amir
    Al-Raddadi, Rajaa M.
    Alvis-Guzman, Nelson
    Amini, Saeed
    Andrei, Tudorel
    Andrei, Catalina Liliana
    Andualem, Zewudu
    Anjomshoa, Mina
    Arabloo, Jalal
    Ashagre, Alebachew Fasil
    Asmelash, Daniel
    Ataro, Zerihun
    Atout, Maha Moh'd Wahbi
    Ayanore, Martin Amogre
    Badawi, Alaa
    Bakhtiari, Ahad
    Ballew, Shoshana H.
    Balouchi, Abbas
    Banach, Maciej
    Barquera, Simon
    Basu, Sanjay
    Bayih, Mulat Tirfie
    Bedi, Neeraj
    Bello, Aminu K.
    Bensenor, Isabela M.
    Bijani, Ali
    Boloor, Archith
    Borzi, Antonio M.
    Camera, Luis Alberto
    Carrero, Juan J.
    Carvalho, Felix
    Castro, Franz
    Catala-Lopez, Ferran
    Chang, Alex R.
    Chin, Ken Lee
    Chung, Sheng-Chia
    Cirillo, Massimo
    [J]. LANCET, 2020, 395 (10225) : 709 - 733
  • [7] RENAL PROTECTIVE EFFECT OF ENALAPRIL IN DIABETIC NEPHROPATHY
    BJORCK, S
    MULEC, H
    JOHNSEN, SA
    NORDEN, G
    AURELL, M
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1992, 304 (6823): : 339 - 343
  • [8] Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey
    Coresh, J
    Astor, BC
    Greene, T
    Eknoyan, G
    Levey, AS
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) : 1 - 12
  • [9] Burden, access, and disparities in kidney disease
    Crews, Deidra C.
    Bello, Aminu K.
    Saadi, Gamal
    Li, Philip Kam Tao
    Garcia-Garcia, Guillermo
    Andreoli, Sharon
    Crews, Deidra
    Kalantar-Zadeh, Kamyar
    Kernahan, Charles
    Kumaraswami, Latha
    Saadi, Gamal
    Strani, Luisa
    [J]. NEFROLOGIA, 2020, 40 (01): : 4 - 11
  • [10] The 2021-2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD
    de Sa, Joao Roberto
    Rangel, Erika Bevilaqua
    Canani, Luis Henrique
    Bauer, Andrea Carla
    Escott, Gustavo Monteiro
    Zelmanovitz, Themis
    Bertoluci, Marcello Casaccia
    Silveiro, Sandra Pinho
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01)